A novel pathological role of p53 in kidney development revealed by gene-environment interactions

Am J Physiol Renal Physiol. 2005 Jan;288(1):F98-107. doi: 10.1152/ajprenal.00246.2004. Epub 2004 Sep 21.

Abstract

Gene-environment interactions are implicated in congenital human disorders. Accordingly, there is a pressing need to develop animal models of human disease, which are the product of defined gene-environment interactions. Previously, our laboratory demonstrated that gestational salt stress of bradykinin B(2) receptor (B(2)R)-null mice induces renal dysgenesis and early death of the offspring. In contrast, salt-stressed B(2)R +/+ or +/- littermates have normal development. The present study investigates the mechanisms underlying the susceptibility of B(2)R-null mice to renal dysgenesis. Proteomic and conventional Western blot screens identified E-cadherin among the differentially repressed proteins in B(2)R-/- kidneys, whereas the checkpoint kinase Chk1 and its substrate P-Ser(20) p53 were induced. We tested the hypothesis that p53 mediates repression of E-cadherin gene expression and is causally linked to the renal dysgenesis. Genetic crosses between B(2)R -/- and p53+/- mice revealed that germline reduction of p53 gene dosage rescues B(2)R-/- mice from renal dysgenesis and restores kidney E-cadherin gene expression. Furthermore, gamma-irradiation induces repression of E-cadherin gene expression in p53+/+ but not -/- cells. In transient transfection assays, p53 repressed human E-cadherin promoter-driven reporter activity, whereas a mutant p53, which cannot bind DNA, did not. Functional promoter analysis indicated the presence of a p53-responsive element in exon 1, which partially mediates p53-induced repression. Chromatin immunoprecipitation assays revealed that p53 inhibits histone acetylation of the E-cadherin promoter. Treatment with a histone deacetylase inhibitor reversed both p53-mediated promoter repression and deacetylation. In conclusion, this study demonstrates that gene-environment interactions cooperate to induce congenital defects through p53 activation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Animals, Newborn
  • Base Sequence
  • Cadherins / genetics
  • Cadherins / metabolism
  • Cell Line
  • Checkpoint Kinase 1
  • Female
  • Gene Expression Regulation, Developmental / physiology*
  • Kidney / abnormalities*
  • Kidney / embryology
  • Kidney / metabolism
  • Mice
  • Mice, Knockout
  • Molecular Sequence Data
  • Pregnancy
  • Prenatal Exposure Delayed Effects
  • Protein Kinases / metabolism
  • Receptor, Bradykinin B2 / genetics
  • Sodium Chloride / pharmacology
  • Tumor Suppressor Protein p53 / physiology*

Substances

  • Cadherins
  • Receptor, Bradykinin B2
  • Tumor Suppressor Protein p53
  • Sodium Chloride
  • Protein Kinases
  • CHEK1 protein, human
  • Checkpoint Kinase 1
  • Chek1 protein, mouse